Annual CAPEX
N/A
December 1, 2024
Summary
- ABBV annual capital expenditures is not available.
Performance
ABBV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
December 1, 2024
Summary
- ABBV quarterly capital expenditures is not available.
Performance
ABBV Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
December 1, 2024
Summary
- ABBV TTM capital expenditures is not available.
Performance
ABBV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ABBV CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ABBV CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
AbbVie CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $249.00 M(+3.3%) | $888.00 M(+3.5%) |
| Jun 2024 | - | $241.00 M(+24.9%) | $858.00 M(+7.9%) |
| Mar 2024 | - | $193.00 M(-5.9%) | $795.00 M(+2.3%) |
| Dec 2023 | $777.00 M(+11.8%) | $205.00 M(-6.4%) | $777.00 M(-1.0%) |
| Sep 2023 | - | $219.00 M(+23.0%) | $785.00 M(+5.7%) |
| Jun 2023 | - | $178.00 M(+1.7%) | $743.00 M(+4.9%) |
| Mar 2023 | - | $175.00 M(-17.8%) | $708.00 M(+1.9%) |
| Dec 2022 | $695.00 M(-11.7%) | $213.00 M(+20.3%) | $695.00 M(+3.9%) |
| Sep 2022 | - | $177.00 M(+23.8%) | $669.00 M(-5.6%) |
| Jun 2022 | - | $143.00 M(-11.7%) | $709.00 M(-6.8%) |
| Mar 2022 | - | $162.00 M(-13.4%) | $761.00 M(-3.3%) |
| Dec 2021 | $787.00 M(-1.4%) | $187.00 M(-13.8%) | $787.00 M(-10.5%) |
| Sep 2021 | - | $217.00 M(+11.3%) | $879.00 M(0.0%) |
| Jun 2021 | - | $195.00 M(+3.7%) | $879.00 M(+2.1%) |
| Mar 2021 | - | $188.00 M(-32.6%) | $861.00 M(+7.9%) |
| Dec 2020 | $798.00 M(+44.6%) | $279.00 M(+28.6%) | $798.00 M(+17.0%) |
| Sep 2020 | - | $217.00 M(+22.6%) | $682.00 M(+10.2%) |
| Jun 2020 | - | $177.00 M(+41.6%) | $619.00 M(+8.6%) |
| Mar 2020 | - | $125.00 M(-23.3%) | $570.00 M(+3.3%) |
| Dec 2019 | $552.00 M(-13.5%) | $163.00 M(+5.8%) | $552.00 M(+7.8%) |
| Sep 2019 | - | $154.00 M(+20.3%) | $512.00 M(-20.0%) |
| Jun 2019 | - | $128.00 M(+19.6%) | $640.00 M(+2.2%) |
| Mar 2019 | - | $107.00 M(-13.0%) | $626.00 M(-1.9%) |
| Dec 2018 | $638.00 M(+20.6%) | $123.00 M(-56.4%) | $638.00 M(-8.5%) |
| Sep 2018 | - | $282.00 M(+147.4%) | $697.00 M(+28.8%) |
| Jun 2018 | - | $114.00 M(-4.2%) | $541.00 M(-2.2%) |
| Mar 2018 | - | $119.00 M(-34.6%) | $553.00 M(+4.5%) |
| Dec 2017 | $529.00 M | $182.00 M(+44.4%) | $529.00 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $126.00 M(0.0%) | $461.00 M(+2.9%) |
| Jun 2017 | - | $126.00 M(+32.6%) | $448.00 M(-1.1%) |
| Mar 2017 | - | $95.00 M(-16.7%) | $453.00 M(-5.4%) |
| Dec 2016 | $479.00 M(-10.0%) | $114.00 M(+0.9%) | $479.00 M(-6.1%) |
| Sep 2016 | - | $113.00 M(-13.7%) | $510.00 M(-2.7%) |
| Jun 2016 | - | $131.00 M(+8.3%) | $524.00 M(+3.1%) |
| Mar 2016 | - | $121.00 M(-16.6%) | $508.00 M(-4.5%) |
| Dec 2015 | $532.00 M(-13.1%) | $145.00 M(+14.2%) | $532.00 M(-1.5%) |
| Sep 2015 | - | $127.00 M(+10.4%) | $540.00 M(-8.9%) |
| Jun 2015 | - | $115.00 M(-20.7%) | $593.00 M(-4.4%) |
| Mar 2015 | - | $145.00 M(-5.2%) | $620.00 M(+1.3%) |
| Dec 2014 | $612.00 M(+24.6%) | $153.00 M(-15.0%) | $612.00 M(+0.3%) |
| Sep 2014 | - | $180.00 M(+26.8%) | $610.00 M(+8.3%) |
| Jun 2014 | - | $142.00 M(+3.6%) | $563.00 M(+4.3%) |
| Mar 2014 | - | $137.00 M(-9.3%) | $540.00 M(+10.0%) |
| Dec 2013 | $491.00 M(+47.4%) | $151.00 M(+13.5%) | $491.00 M(+12.9%) |
| Sep 2013 | - | $133.00 M(+11.8%) | $435.00 M(+53.2%) |
| Jun 2013 | - | $119.00 M(+35.2%) | $284.00 M(+9.7%) |
| Mar 2013 | - | $88.00 M(-7.4%) | $259.00 M(-22.2%) |
| Dec 2012 | $333.00 M(-6.5%) | $95.00 M(-627.8%) | $333.00 M(-2.9%) |
| Sep 2012 | - | -$18.00 M(-119.1%) | $342.89 M(-19.1%) |
| Jun 2012 | - | $94.00 M(-42.0%) | $424.06 M(+0.7%) |
| Mar 2012 | - | $162.00 M(+54.4%) | $421.15 M(+18.3%) |
| Dec 2011 | $356.00 M(-20.5%) | $104.89 M(+66.1%) | $356.00 M(+41.8%) |
| Sep 2011 | - | $63.17 M(-30.7%) | $251.10 M(+33.6%) |
| Jun 2011 | - | $91.09 M(-5.9%) | $187.94 M(+94.1%) |
| Mar 2011 | - | $96.85 M | $96.85 M |
| Dec 2010 | $448.00 M(+43.3%) | - | - |
| Dec 2009 | $312.56 M | - | - |
FAQ
- What is the all time high annual CAPEX for AbbVie?
- What is the all time high quarterly CAPEX for AbbVie?
- What is the all time high TTM CAPEX for AbbVie?
What is the all time high annual CAPEX for AbbVie?
AbbVie all-time high annual capital expenditures is $798.00 M
What is the all time high quarterly CAPEX for AbbVie?
AbbVie all-time high quarterly capital expenditures is $282.00 M
What is the all time high TTM CAPEX for AbbVie?
AbbVie all-time high TTM capital expenditures is $888.00 M